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Abstract
BACKGROUND: Prolonged exposure to stress is known to change homeostasis and can lead to the development 
of psychopathological disorders, including depression. Exposure to stress factors contributes to the emergence of 
reactive oxygen species in the brain. The data characterizing changes of the oxidative metabolism under conditions 
of chronic stress are insufficient, which determine the relevance of the research in this direction. The determination 
of reactive carbonyl derivatives of proteins (RCDP), methylglyoxal (MG), and malondialdehyde (MDA) levels can be 
considered an informative method for studying the dynamics of oxidative metabolism.
AIM: The aim of the study was to study the RCDP, MG, and MDA in red blood cells and blood plasma in rats 
experiencing chronic unpredictable moderate stress (CUMS).
METHODS: A total of 20 male outbred rats weighing 450–500 g were used in the study. The animals were divided 
into two groups of ten rats each using randomized selection. The experimental group of animals was exposed to the 
impact of diverse stress factors, according to the CUMS model for 21 days. The control group of animals remained 
in standard conditions and did not undergo CUMS model. Blood sampling was performed twice for all rats the day 
before the experiment started and on 21st day to determine the level of RCDP, MG, and MDA in their erythrocytes 
and blood plasma.
RESULTS: The study revealed a significant decrease of RCDP (p = 0.007) and MDA levels in erythrocytes (p = 
0.013), and MDA level in blood plasma (p = 0.005) of rats of the main experimental group. The control group showed 
a significant increase of RCDP level in plasma (p = 0.008), a two-fold increase of MDA in erythrocytes (p = 0.05) with 
a decrease of MDA in plasma (p = 0.011). A tendency for MG increase was noted in erythrocytes of rats in both the 
main group and the control group.
CONCLUSION: The early stages of CUMS were accompanied by the violation of oxidative metabolism with the 
emergence and accumulation of RCDP and MDA in the blood of animals. The decreased emergence of RCDP 
and MDA in the later stages can be associated with an excess of oxidized substrates in the blood of animals of 
the experimental group. The revealed trend toward MG growth in animals of both groups suggests its increased 
synthesis in erythrocytes, which, in our opinion, should be considered a negative factor affecting the deformability 
of red cells. In turn, a violation of the deformability of red blood cells leads to a violation of microcapillary blood flow, 
which contributes to the development of hypoxic damage in different tissues. Thus, the obtained data confirm the 
different directions of changes in RCDP and MDA levels in the blood of animals experiencing CUMS or acute stress. 
Our results prove the need for further research on changes in oxidative metabolism in chronic stress disorders.
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Introduction
Stress is considered one of the important 
causes of somatic and mental pathology, including 
adaptation disorders [1], [2]. Enough data have 
been obtained confirming the direct relation of stress 
with the development of depression [3], [4]. Stress 
changes homeostasis, affects the neuroendocrine 
and immune systems, and leads to the evolvement of 
psychopathological syndromes [5], [6].
Reactions to acute stress (AS) and chronic stress 
suggest various biochemical changes and subsequent 
behavioral disorders. It has been established that under 
the influence of stress factors the level of reactive 
oxygen species in the brain increases [7], [8]. Separate 
sporadic studies demonstrate certain differences in 
the direction of the oxidative metabolism reactions in 
tissues during acute and chronic stress [9].
The mechanism of influence of chronic stress 
is of greatest interest to researchers. Chronic stress is 
known to trigger the release mechanism for a significant 
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number of neurotransmitters with the formation of a 
 pro-inflammatory response of microglia and to cause 
structural changes in neuroglia [10], [11], [12]. Chronic 
stress alters the expression of genes that regulate 
antioxidant enzymes such as catalase, glutathione 
peroxidase, nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase, superoxide dismutase, and glutathione 
reductase [13], [14], [15]. Activation of lipid peroxidation 
and inhibition of the mitochondrial respiratory chain are 
shown in the model of chronic immobilization stress [16]. 
A study of patients with depression and bipolar disorder 
revealed a decrease in antioxidant protection and an 
increase in the level of lipid peroxidation in blood [17], [18]. 
A new meta-analysis confirmed an increased level of 
8-hydroxy-2’-deoxyguanosine and F2-isoprostanes in 
tissues and biological fluids, marking increased oxidative 
damage to DNA and lipids in patients with bipolar disorder 
and various types of depression [19].
Changes in oxidative metabolism under the 
influence of chronic stress are an important aspect 
of understanding its damaging effects. Studies show 
changes in levels of oxidative stress markers in mental 
and neurological pathologies. An increase in the level 
of malondialdehyde (MDA) and the number of carbonyl 
groups is recorded in cerebral ischemia [20]. The 
damaging effect of methylglyoxal (MG) is mediated by the 
formation of MG-modified proteins with the development 
of carbonyl stress in neuroblastomas [21]. The process 
of inactivation of proteins by the oxygen active species 
is a direct factor in the development of carbonyl stress 
with the succeeding progression of neurodegenerative 
disorders [22], [23], [24]. A significant number of 
researchers conducted studies of isolated indicators of 
carbonyl stress or its end products in the already evolved 
pathological conditions. However, according to available 
data, exposure to chronic stress leads to activation of 
oxidative stress mechanisms with stimulation of the 
“hypothalamus–pituitary–adrenal gland” chain reaction 
with ensuing systemic damage [25]. Thus, the study 
of neuron-specific markers and isolated fractions of 
carbonyl proteins in our study were not justified, while 
reactive carbonyl derivatives of proteins (RCDP), MG, 
and MDA could be considered the most informative 
indicators of oxidative stress and can be used as 
markers of oxidative damage at the stage of pathology 
formation and as a control for further therapy.
An analysis of the literature data showed, that 
markers of the state of oxidative metabolism, such 
as RCDP, MG, and MDA, have hardly been studied 
under conditions of chronic stress, which explains the 
relevance of this study.
Protein carbonylation is a common protein 
modification mechanism. Carbonyl derivatives can 
appear in different ways: As a result of direct oxidation 
of the amino acid residues of lysine, arginine, proline 
and threonine, or under the action of reactive oxygen 
species, as well as in reactions with carbonyl-containing 
oxidized lipids. Other carbonylation pathways include 
protein fragmentation, α-amidation, and oxidation of 
glutamine side chains [26]. Protein carbonylation is 
an irreversible process leading to a loss of proteins’ 
functions. Under physiological conditions carbonylation 
plays an important role in protein quality control and 
protein metabolism. Increased carbonylation leads to 
accumulation of proteolysis-resistant aggregates of 
oxidized proteins [27]. Some of neurodegenerative 
diseases are associated with the accumulation of 
carbonylated protein aggregates in cells and tissues [28].
MG appears mainly in the process of 
glycolysis from glyceroaldehyde-3-phosphate and 
dioxiaacetonphosphate. The utilization of MG into 
D-lactate occurs through the glyoxylase system with 
the participation of reduced glutathione. The pentose 
phosphate pathway is also involved in the metabolism 
of MG as a source of NADPH, which is necessary for 
the reduction of oxidized glutathione. MG is a highly 
reactive dicarbonyl, capable of forming adducts with 
proteins and nucleic acids, leading to the loss of their 
biological functions [29].
MDA is the product of arachidonic acid and other 
polyunsaturated fatty acids decomposition and appears 
as a result of enzymatic and non-enzymatic reactions. 
The functions of MDA are currently under active study. It 
is known that MDA can work as a signal messenger, as 
well as regulate the expression of a number of genes. 
On the other hand, MDA is able to form adducts with 
proteins and DNA, which leads to disruption of their 
structure and loss of biological functions [30].
The aim of our study is to examine changes in 
the levels of RCDP, MG, and MDA in red blood cells and 
blood plasma in rats experiencing chronic unpredictable 
moderate stress (CUMS).
Methods
To reproduce the conditions of chronic 
stress, a model that met the criteria of credibility and 
reliability was selected. In recent years, the model 
of “CUMS” has confirmed its position as a reference 
model for the study of the neurobiological basis of 
stress-induced disorders and the development of new 
antidepressants [31], [32], [33].
Selection and description of participants
A total of 20 male outbred rats weighing 450–
500 g. were used in the study. The animals were kept 
(five rats per cage) under standard laboratory conditions 
(25 ± 2°C, humidity 60–70%), maintaining a 12-h 
natural day-night cycle with free access to standard 
food and water. The quarantine and keeping conditions 
of the animals before the start of the experiment met 
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the established requirements. The rats were divided 
into two groups ten animals each using randomized 
selection. The study was conducted in accordance with 
the requirements of the European Convention for the 
Protection of Vertebrate Animals Used in Experiments 
and Other Scientific Purposes (Strasbourg, 1986), 
requirements of GLP OECD, EAEU Rules of Good 
Laboratory Practice No. 81, order of the Ministry of 
Health and Social Development of the Republic of 
Kazakhstan No. 392 dated May 25, 2015. The study 
was approved by the decision of the Committee on 
Bioethics of the Karaganda Medical University on June 
17, 2019, protocol No. 65.
Technical information
The experimental group of animals was 
exposed to the CUMS, while the comparison control 
group was kept in standard conditions without CUMS. 
Animals of the two groups underwent behavioral testing 
and blood sampling procedure. Thus, the animals of the 
control group can be considered an animal model of 
AS, which was caused in animals 4 times during the 
study period.
Behavioral assessments
Animals of the two groups were tested 
according to the standard protocols in the “open field 
test” [34], “the elevated cross-maze test” [35], “tail-
hanging test” [36], [37], and “sucrose preference 
test” [38]. Behavioral tests were performed on the day 
preceding the start of the experiment, designated as 
first control point, and at the end of each cycle of the 
CUMS model, which corresponded to the 7th, 14th, and 
21st days of the experiment. The day of the behavioral 
tests additional stress factors were absent, since the 
animals were placed into the new environment for the 
behavioral testing and that can be considered as a 
stressful factor itself. A rest period of 1 h was allowed in 
between each trial.
Animals in two groups underwent the blood 
sampling from the tail vein, blood being gathered into 
heparinized tubes. The procedure was performed 
under light ether anesthesia on the day preceding the 
start of the experiment, designated as first control point, 
and on the 21st day of the experiment, designated as a 
second control point. Blood sampling in animals was 
carried out after behavioral testing, since the blood 
sampling procedure and the effects of ether anesthesia 
could have affected the results of behavioral tests and 
had been a significant stress factor.
Experimental procedure for CUMS model
For 21 days, the animals of the main 
experimental group were experiencing the trials 
according to the “CUMS” model, presented in Table 1 
(three cycles of 7 days each).
Table 1: Exposure schedule for rats of the main group, leading 
to formation of the chronic unpredictable moderate stress 
model
Type of 
exposure
Day of experiment cycle Control test
1 2 3 4 5 6 7
Narrow cell 12.00–08.00 Behavioral 
tests
Food 
deprivation
8.00–08.00
Immobilization 
in a case
10.00–14.00
Shading during 
daylight hours
6.00–21.00
Water 
deprivation
8.00–18.00
Artificial light 
during night 
hours
19.00–10.00
Full 
immobilization
10.00–12.00
Types of exposure used to form the CUMS 
model:
• Narrow cell – limiting the space of the cell 
by half due to the installation of an additional 
partition in the cell
• Food deprivation – food deprivation for 24 h
• Immobilization in a case – animals are placed 
in individual cases, which do not deprive them 
of the ability to move, but greatly limit the space 
for movement
• Shading during daylight hours – artificial 
dimming during daylight hours, lasting 15 h
• Water deprivation – deprivation of water for 10 h
• Artificial light during night hours – creating artificial 
lighting in the nighttime hours, lasting 15 h
• Full immobilization – placing animals in 
individual canisters, depriving them of the 
ability to move for 2 h.
Spectrophotometric study
Blood samples obtained during the study were 
transferred to the laboratory, where they underwent 
centrifugation and analysis of the collected materials 
by spectrophotometry using a PD-303 ultraviolet (UV) 
digital UV-VIS spectrophotometer, manufactured by 
APEL, Japan.
Determining RCDP
We measured the concentration of RCDP 
following the well-tested protocol of Levine et al. [39], [40]. 
To triplicate aliquots of plasma (0.8 mL), we added 0.2 mL 
of 10% trichloroacetic acid solution and centrifuged the 
samples. Then, either 1 mL of 2M HCl liquid solution or 
10 mL of 2.4-dinitrophenylhydrazine (DNPH) in 2M HCl 
solution was added to the precipitates, and further this 
mixture was incubated at 37°C for 90 min. Next, the 
samples were centrifuged again (8000 rpm, 10 min) 
and the DNPH excess was removed with ethanol-ethyl 
acetate 1:1 (v/v). Finally, the samples were re-suspended 
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in 6M of guanidine hydrochloride. Quantification was 
performed using a spectrophotometer PD - 303 UV 
APEL (Japan) at a 366 nm absorbance. Concentration 
of carbonyl derivatives was calculated using the molar 
absorption coefficient of 22,000 mol/cm−1, RCDP values 
were given in nmol/ml.
Determining MGs
MG was determined by reaction with 
dinitrophenylhydrazine according to a modified Racker 
method [41]. We combined 25 μl of blood sample with 
350 μl of DNPH (0.1% DNPH in 2N HCl) and then 
added 2.125 mL of distilled water to each tube. Finally, 
we incubated samples for 15 min at 37oC and after the 
incubation added 1.5 mL of 10% NaOH. The absorbance 
for spectrophotometer was set at 576 nm; MG levels 
were expressed in percent absorbance of MG.
Determining MDA
MDA in red blood cells was determined according 
to the protocol of Goncharenko and Latypova [42]. To 
determine MDA, erythrocytes were washed in 10 mL of 
chilled saline, and then centrifuged for 10 min at 3000 rpm. 
The washed red blood cells were hemolyzed with distilled 
water with a 1:5 ratio. For the study, we took 0.3 mL of 
hemolysate, added 0.3 mL of 10% phosphotungstic acid 
and 10 min later centrifuged the samples at 3000 rpm 
for 10 min. The resulting precipitate was washed with 
1 mL of distilled water and centrifuged once again. Then, 
3 mL of water and 1 mL of thiobarbituric acid (80 mg 
of tert-butyl alcohol in a mixture of 5 mL of water and 
5 mL of acetic acid) were added to the precipitate and 
incubated for 60 min in a boiling water bath. Finally, the 
solution was centrifuged and tested for absorbance at 
spectrophotometer set at 532 nm against water. In the 
calculations, we used the molar extinction coefficient, 
which is 1.56 × 105M/cm−1 expressed in μmol/mL.
Statistics
The results were statistically processed using 
the SPSS.Statistics.v22. multilingual-EQUiNOX (SPSS 
Inc.) software.
Analysis of the obtained data was conducted 
using descriptive statistics. The comparison of oxidized 
metabolism before and after the experiment was carried 
out using the non-parametric Wilcoxon t-test (α = 0.05).
Results
To compare the studied parameters in blood 
plasma and erythrocytes on the first and second control 
points (a day before the experiment and 21st day of 
the experiment), the non-parametric Wilcoxon t-test 
(α = 0.05) was used, where statistically significant 
differences were accepted at p ≤ 0.05.
The results of studies in the main group, 
presented in Table 2, show a reliably significant decrease 
of RCDP level in erythrocytes by 1.67 times (median, 
p = 0.007), MDA level in plasma (p = 0.005), and MDA 
level in erythrocytes (p = 0.013) on the 21st day of the 
experiment. A tendency toward a decrease in RCDP 
level in blood plasma and MG level in erythrocytes of 
rats of the main group was also revealed.
Table 2: RCDP, MDA levels in plasma and RCDP, MDA, MG 
levels in erythrocytes in the main group
Indicator Median (Q25; Q75) 
before the experiment
Median (Q25; Q75) 
after the experiment
p
RCDP in erythrocytes 10,74 (9,498;12,81) 6,403 (3,939;8,866) 0,007
MDA in erythrocytes 10,00 (8,846;10,90) 9,231 (8,077;19,49) 0,013
MG in erythrocytes 0,615 (0,573;0,639) 0,757 (0,728;0,828) 0,445
RCDP in plasma 1,052 (0,857;1,134) 0,996 (0,848;1,212) 0,878
MDA in plasma 1,720 (1,694;1,774) 1,548 (1,350;1,668) 0,005
MG: Methylglyoxal, RCDP: Reactive carbonyl derivatives of proteins, MDA: Malondialdehyde.
Table 3 shows the results of a study of the 
target parameters in the blood of rats of the comparison 
group. On the 21st day of the experiment, there was a 
significant increase of RCDP level in plasma (p = 0.008) 
and MDA in erythrocytes twice from the initial level 
(p = 0.05), while MDA in plasma decreased (p = 0.011). 
There also was a tendency toward an increase of 
RCDP and MG levels in the erythrocytes of rats of the 
comparison group.
Table 3: RCDP, MDA levels in plasma and RCDP, MDA, MG 
levels in erythrocytes in the comparison group
Indicator Median (Q25; Q75) 
before the experiment 
Median (Q25; Q75) 
after the experiment 
p
RCDP in erythrocytes 1.983 (1.792;2.121) 2.424 (1.662;3.013) 0.441
MDA in erythrocytes 6.795 (5.769;8.077) 13.97 (8,718;21.54) 0.050
MG in erythrocytes 0.787 (0.758;0.897) 0.807 (0.676;0.831) 0.575
RCDP in plasma 0.628 (0.606;0.753) 1.377 (1.117;1.411) 0.008
MDA in plasma 2.250 (1.694;2.833) 1.482 (1.376;1.508) 0.011
MG: Methylglyoxal, RCDP: Reactive carbonyl derivatives of proteins, MDA: Malondialdehyde.
The results of the study show that the levels 
of RCDP and MDA are reduced in blood plasma and 
in erythrocytes of the animals experiencing CUMS. 
At the same time, in animals with AS the revealed 
changes in the studied parameters have the opposite 
direction, which are documented by an increase in the 
content of RCDP in blood plasma and erythrocytes 
and MDA in erythrocytes. At the same time, a 
decrease of MDA level in the blood plasma of animals 
with an AS factors was recorded. In other words, we 
found that oxidative stress markers levels change in 
opposite directions depending on the type of stress 
factors exposure.
Discussion
According to the generally accepted theory 
of the effect of stress on the body, the development 
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of stress-induced disorders directly depends on the 
adaptation mechanisms, duration, and strength of the 
stress factor influence and neurobiological vulnerability 
to behavioral disorders [32]. Available studies indicate 
that each stress model has a different effect on the 
tissues of various organs [43]. These assumptions are 
confirmed in our study. The data obtained from the 
study of animals in the model of chronic stress show 
predominant damage in red blood cells, which may 
explain, among other things, damage to the central 
nervous system with the formation of stress-induced 
disorders. The study of the mechanisms of the stress, 
affecting biochemical processes through a change in the 
oxidative modification of proteins and lipid peroxidation, 
still continues.
In our experiment, the CUMS and AS 
models were used to form chronic and AS-induced 
disorders. The CUMS model implies daily exposure 
to unpredictable stress factors of small strength. In 
addition, behavioral reactions were studied in animals 
of this group.
In the AS model, the animals were not subjected 
to daily stress exposure of low strength, but they were 
tested in behavioral tests. The behavioral assessment 
procedure included a “tail suspension test,” which in 
itself can be considered as a rather traumatic, if AS 
factor [44].
Our results of assessing the RCDP and MDA 
levels allowed us to conclude that the development of 
carbonyl stress in the blood and the activation of lipid 
peroxidation in rat blood with a model of AS happen 
simultaneously. At the same time, a decrease of RCDP 
and MDA levels was observed on the 21st day of the 
experiment in the blood of rats experiencing CUMS. 
In our opinion, the following assumption can be made 
as a hypothesis: In all likelihood, the early stages of 
CUMS were accompanied by the violation of oxidative 
metabolism with the emergence and accumulation of 
RCDP and MDA in the blood of animals. The decreased 
emergence of RCDP and MDA in the later stages can 
be associated with an excess of oxidized substrates 
in the blood of animals of the experimental group. The 
revealed trend toward MG growth in animals of both 
groups suggests its increased synthesis in erythrocytes, 
which, in our opinion, should be considered a negative 
factor affecting the deformability of red cells [45]. In 
turn, a violation of the deformability of red blood cells 
leads to a violation of microcapillary blood flow, which 
contributes to the development of hypoxic damage in 
different tissues.
When comparing the results in the main group 
and in the comparison group, various trends of changes 
after the experiment were revealed. Hence, the 
concentration of RCPD in the plasma and erythrocytes 
of rats of the main group showed a pronounced increase 
after the experiment (by 111% and 77%, respectively). 
In the comparison group, such changes were not 
observed: There was no significant growth in plasma 
RCPD level and, contrariwise, even a decrease in the 
concentration of RCPD by 41% in red blood cells was 
noted.
Changes in the concentration of MDA in blood 
plasma and red blood cells were unidirectional in both 
groups, but with varying degrees of severity. Hence, 
in the red blood cells of rats of the main group the 
concentration of MDA after the experiment increased 
by 177%, while in the comparison group there was 
only an increase by 25%. In the blood plasma of rats 
of the main group a decrease in the concentration of 
MDA by 40% was noted, while in the comparison group 
the decrease in concentration was only at the 15% 
level. Changes in the concentration of MG in the blood 
of rats of the main group were not pronounced, while 
in the comparison group the concentration increased 
by 28%. The revealed differences in the results 
dynamics in the groups demonstrate involvement of the 
separate oxidative metabolism elements in the various 
pathological mechanisms of acute and chronic stress 
formation. According to the results of the obtained data, 
the predominant accumulation of oxidative metabolites 
in red blood cells was revealed, which is a factor of 
subsequent hypoxic tissue damage. The changes in 
the MG level which does not correlate with the levels 
of RCDP and MDA, in our opinion, can be explained 
by its predominant accumulation in tissues, where 
under the conditions of oxidative stress it mediates the 
maximum damaging effect. This assumption requires 
further study of tissue indicators of MG concentration. 
A significant increase in the level of MDA in red blood 
cells in the main group, in our opinion, may be a cause 
of the early death of erythrocytes and the loss of their 
biological functions due to the high degree of toxicity of 
the MDA molecule [46]. The accumulation of RCDP in 
turn contributes to inhibition of mitochondrial respiration 
function with the development of ensuing tissue hypoxia.
Conclusion
Thus, the obtained data confirm the different 
directions of changes in RCDP and MDA levels in the 
blood of animals experiencing CUMS and AS. Our 
results prove the need for further research on changes 
in oxidative metabolism in chronic stress disorders.
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